Dedicated to advancing and optimizing the clinical laboratory, Beckman Coulter is a reliable manufacturer of quality hematology analyzers, flow cytometers and coagulation analyzers. The company recently announced its partnership with U.S. ARKRAY, Inc. (ARKRAY) and the launch of the iQ Urinalysis Workcell.
The iQ Workcell combines two of the world's most reputable automated urine analyzers - the Beckman Coulter Iris iQ200 Digital Flow Morphology system and the ARKRAY AUTION MAX AX-4030. Beckman Coulter will also offer both the ARKRAY AUTION MAX AX-4030 and the ARKRAY AUTION ELEVEN® AE-4022 analyzers as stand-alone solutions, reinforcing the company's commitment to provide scalable solutions for high-, mid-, and low-volume laboratory needs.
A scalable solution, the iQ Workcell is offered in three configurations-iQ 3000, 2000 and 1500 Workcells- to meet laboratories' workflow needs. While the Beckman Coulter's proprietary Digital Flow Morphology process auto-classifies 12 particle types with 27 sub-categories and reduces subjectivity during data analysis, the ARKRAY urine chemistry strips have broad measuring ranges for expanded clinical utility.
This total urinalysis offering became available in the U.S. exclusively through Beckman Coulter starting July 31, 2018 and this partnership help both the companies to meet the needs of their growing customer bases.
Peter Soltani, Ph.D., Senior Vice President and General Manager of the hematology and urinalysis business at Beckman Coulter said, "Beckman Coulter's partnership with ARKRAY allows us to build on our more than 30-year heritage of simplifying the urinalysis workflow and meeting our customers' growing needs. The iQ Workcell combines our world-class Digital Flow Morphology imaging particle analysis with ARKRAY's robust and reliable urine chemistry analyzer. This, in conjunction with the AUTION ELEVEN AE-4022, allows us to provide a scalable, harmonized portfolio in the United States."